Northwestern Nanodiamonds Kill the Cancer Left Behind
Scientists at Northwestern University develop a nanodevice that delivers drugs to residual cancer cells left in the body after tumor surgery.
click here to read full article...All UK Cancer Patients Will Get Information on Clinical Trials
To boost recruiting and improve awareness, government officials in the United Kingdom plan to routinely inform all NHS cancer patients about clinical trials.
click here to read full article...Lipidoids Could Deliver RNAi Treatments Directly to Cancer
Scientists from the Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY) have discovered a method which makes it possible to deliver powerful RNA interference (RNAi) therapies directly to the precise location where cancer or viral infections are developing.
RNAi therapies are designed to turn on and off disease-causing genes. Early [...]
Prostate Cancer Treatment Effectiveness Could Rely on P53
A study led by the Fred Hutchinson Cancer Research Center suggests that tumors with intact P53 genes may respond better to prostate cancer treatments designed to target insulin-like growth factor 1 receptors (IGF-1R).
Fred Hutchinson’s findings could have an important impact on more than a dozen clinical trials currently being conducted to test [...]
MPD Blood Cancer Treatment Begins Human Trials
Researchers at the Dana-Farber Cancer Institute have begun Phase I clinical trials of a new drug designed to treat myeloproliferative diseases (MPD) that sometimes develop into acute myelogenous leukemia (AML).
Scientists at Brigham and Women’s Hospital have already used the new drug, an orally-administered compound known as TG101348, to successfully treat chronic blood cancers in mice. [...]
Boston Builds Better Mouse Model for Metastatic Cancer
Biologists at Boston College have developed a more effective mouse model for studying how cancer spreads through the human body.
Boston’s team developed two cell lines which express all the major biological characteristics of human metastatic cancer only three weeks after being injected into healthy laboratory mice. In typical mouse models, researchers must [...]
Campaign Calls for Alternative Treatments in Clinical Trials
An alternative health company is asking citizens of the United Kingdom to support legislation which would include herbal supplements and other natural treatments in clinical trials comparing the effectiveness of investigational drugs against a placebo.
Sweet Cures of York, a marketer of herbal products and natural remedies, has launched a campaign to gain public support for [...]
Cream Treats Precancerous Vulva Lesions Linked to HPV
Dutch scientists have published a study showing a topical cream called imiquimod effectively treats lesions on the vulva before they become cancerous – a discovery that could one day help women exposed to the human papillomavirus (HPV) avoid cancer surgery on their genitals.
The American Cancer Society predicts that approximately 3,500 new cases of vulvar cancer [...]
Melanoma Treatment Trials Halted by Pfizer
Pharmaceutical company Pfizer Inc (NYSE: PFE) has announced they’re discontinuing Phase III clinical trials on tremelimumab, an experimental treatment for melanoma.
The company terminated the trials because their research indicates the developmental drug is no more effective than existing chemotherapies already approved to treat the potentially deadly skin cancer.
A representative from Pfizer Global [...]
Wake Forest Finds Oxaliplatin Dosage for Peritoneal Cancer
Researchers from Wake Forest University have completed a Phase I study that may help improve the survival rate for patients with appendix cancer or colorectal cancer that’s spread to their abdomen.
Wake Forest’s study identified the maximum amount of a chemotherapy drug peritoneal cancer patients can successfully tolerate during Intraperitoneal Hyperthermic Chemotherapy (IPHC) treatments following [...]


